Lay opinion vs evidence: Triglyceride Kinder

Lay opinion often assumes that a DNA test can explain high triglycerides in children. Evidence shows otherwise: GPIHBP1 autoantibody hypertriglyceridemia is diagnosed via specific antibody tests, not consumer genetic tests. MyBody-X and similar tests lack pediatric validation and are not indicated for children. In most cases, elevated triglycerides in children are lifestyle-related (diet, physical activity) or secondary to conditions like obesity or diabetes. A consumer DNA test provides no clinically actionable information here. Evidence grade: human-observational (case reports). Caveat: laypeople overestimate the predictive power of genetic tests; even when a genetic variant is present, effect sizes are small and lifestyle factors dominate. Additionally, EU regulations restrict genetic testing in minors to medically necessary cases. Conclusion: Do not use DNA tests for children with high triglycerides; pursue standard medical workup and, if indicated, specific antibody testing for GPIHBP1.